Top

Published in:

Open Access 01-06-2021 | Literatur kommentiert

Das Lymphödemrisiko von Mammakarzinompatientinnen nach Operation oder Strahlentherapie der Axilla

Author: PD Dr. med. Marciana-Nona Duma

Published in: Strahlentherapie und Onkologie | Issue 6/2021

Auszug

Ziel dieser Studie war es, das Auftreten eines axillären Lymphödems bei Brustkrebspatientinnen („breast cancer-related lymphedema“ [BCRL]) in Abhängigkeit von der axillären Operationsart und der regionalen Lymphknotenbestrahlung („regional lymphnode radiation“ [RLNR]) zu vergleichen. …

Poortmans PM et al (2015) Internal mammary and medial supraclavicular irradiation in breast cancer. N Engl J Med 373(4):317–327CrossRef

Whelan TJ et al (2015) Regional nodal irradiation in early-stage breast cancer. N Engl J Med 373(4):307–316CrossRef

Donker M et al (2014) Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol 15(12):1303–1310CrossRef

Gillespie TC et al (2018) Breast cancer-related lymphedema: risk factors, precautionary measures, and treatments. Gland Surg 7(4):379–403CrossRef

Giuliano AE et al (2017) Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis the ACOSOG Z0011 (alliance) randomized clinical trial. JAMA 318(10):918–926CrossRef

Liljegren G, Holmberg L (1997) Arm morbidity after sector resection and axillary dissection with or without postoperative radiotherapy in breast cancer stage. 1. Results from a randomised trial. Eur J Cancer 33(2):193–199CrossRef

Galimberti V et al (2013) Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial. Lancet Oncol 14(4):297–305CrossRef

Dylke ES, Ward LC, Kilbreath SL (2013) Standardized approach to lymphedema screening. Oncologist 18(11):1242CrossRef

Ancukiewicz M et al (2011) Standardized method for quantification of developing lymphedema in patients treated for breast cancer. Int J Radiat Oncol Biol Phys 79(5):1436–1443CrossRef

Title: Das Lymphödemrisiko von Mammakarzinompatientinnen nach Operation oder Strahlentherapie der Axilla
Author: PD Dr. med. Marciana-Nona Duma
Publication date: 01-06-2021
Publisher: Springer Berlin Heidelberg
Published in: Strahlentherapie und Onkologie / Issue 6/2021
Print ISSN: 0179-7158
Electronic ISSN: 1439-099X
DOI: https://doi.org/10.1007/s00066-021-01762-9

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Das Lymphödemrisiko von Mammakarzinompatientinnen nach Operation oder Strahlentherapie der Axilla

Auszug

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Auszug

Please log in to get access to this content

Other articles of this Issue 6/2021

An easy way to determine bone mineral density and predict pelvic insufficiency fractures in patients treated with radiotherapy for cervical cancer

Lebensqualität der Patientinnen mit DCIS nach brusterhaltender Operation und adjuvanter Strahlentherapie: konventionell fraktioniert vs. hypofraktioniert, mit und ohne Boost

Effect of irradiation on the expression of E-cadherin and β-catenin in early and late radiation sequelae of the urinary bladder and its modulation by NF-κB inhibitor thalidomide

Dosimetric comparison of volumetric modulated arc therapy (VMAT) and high-dose-rate brachytherapy (HDR-BT) for superficial skin irradiation with significant curvature in one or more planes

Long-term results of robotic radiosurgery for non brachytherapy patients with cervical cancer

Early morbidity and dose–volume effects in definitive radiochemotherapy for locally advanced cervical cancer: a prospective cohort study covering modern treatment techniques